Pages that link to "Q36564932"
Jump to navigation
Jump to search
The following pages link to Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia (Q36564932):
Displaying 14 items.
- Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths (Q33412266) (← links)
- Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia (Q33886052) (← links)
- How I treat CLL up front (Q34137158) (← links)
- Hematopoietic stem cell transplantation for chronic lymphocytic leukemia: potential cure for an incurable disease (Q37012037) (← links)
- Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia (Q37059754) (← links)
- Update on Therapy of Chronic Lymphocytic Leukemia (Q37659071) (← links)
- In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis (Q39999458) (← links)
- Biologic prognostic markers and their application in clinical trials and management of chronic lymphocytic leukaemia patients (Q40138593) (← links)
- Flow cytometry APC-tandem dyes are degraded through a cell-dependent mechanism. (Q43279356) (← links)
- Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk (Q46105836) (← links)
- Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients (Q50875343) (← links)
- ZAP-70 in CLL: towards standardization of a biomarker for patient management: history of clinical cytometry special issue (Q80103626) (← links)
- Optimization of flow cytometric measurement of ZAP-70 in chronic lymphocytic leukemia (Q81465347) (← links)
- Spontaneous in vitro apoptosis of de novo chronic lymphocytic leukemia cells correlates with risk of the disease progression (Q87269624) (← links)